In colon cancer, location is important. Evidence is building up to show a significant difference in survival when malignancies emerge on the right side of the colon compared with those that arise on ...

Prophylactic defect closure after endoscopic submucosal dissection (ESD) of the colon was associated with lower rates of delayed bleeding and post-procedure hospital admission, with the benefit more ...

Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as ...

Huntsman Cancer Institute is at the forefront of colorectal cancer treatment, with a multidisciplinary team specializing in modern treatments like neoadjuvant immunotherapy and minimally invasive ...

Caecal cancer and ascending colon cancer had slower rates of metastasis to main nodes compared with transverse colon cancer. Routine prophylactic extended lymphadenectomy for the superior mesenteric ...

Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast ...

The complex condition affected 75 per cent of intestine, requiring major tumour removal Dubai: In an extraordinary advancement in medicine that has the potential to transform colon cancer treatments ...